US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

29.94 -0.57 (-1.87%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
34 35 Next >
News headline image
Better Growth Buy: Eli Lilly vs. Viking Therapeutics ↗
Via The Motley Fool
News headline image
Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Beaten-Down Stocks With Massive Upside Potential ↗
Via The Motley Fool
News headline image
10 Incredible Growth Stocks Poised for Long-Term Gains ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Got $200? 2 Biotech Stocks to Buy and Hold Forever ↗
Via The Motley Fool
News headline image
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment? ↗
The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide. 
Via Investor's Business Daily
News headline image
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value 
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
Why This Weight Loss Drug Company's Stock Surged Today ↗
Via The Motley Fool
News headline image
3 Growth Stocks I'm Loading Up On ↗
Via The Motley Fool
Topics Artificial Intelligence Government
News headline image
Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity ↗
The company just initiated two Phase 3 studies of its weekly under-the-skin shot to stoke weight loss. 
Via Investor's Business Daily
News headline image
What's Going On With Viking Therapeutics Stock On Wednesday? ↗
Viking Therapeutics begins Phase 3 trials for VK2735, testing weekly injections in over 5,000 adults with obesity or type 2 diabetes over 78 weeks. 
Via Benzinga
News headline image
My 5 Favorite Dirt Cheap Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence Economy World Trade
News headline image
Amgen Expands Development Plans For Highly Anticipated Obesity Drug ↗
Amgen is expanding its plans for weight-loss drug, MariTide, with a trio of upcoming Phase 3 studies. 
Via Investor's Business Daily
News headline image
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts ↗
Via The Motley Fool
News headline image
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside. ↗
Via The Motley Fool
News headline image
Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks? ↗
Via The Motley Fool
Topics Government
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
1 Stock Down 34% This Year to Buy and Hold ↗
Via The Motley Fool
News headline image
Could Viking Therapeutics Become the Next Eli Lilly? ↗
Via The Motley Fool
News headline image
3 Best Growth Stocks to Buy in June ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Government
News headline image
Better Weight Loss Stock: Amgen or Viking Therapeutics? ↗
Via The Motley Fool
News headline image
Why Viking Therapeutics Stock Bumped 3% Higher Today ↗
Via The Motley Fool
News headline image
Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price ↗
Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition. 
Via Investor's Business Daily
News headline image
Why Weight-Loss Developer Stocks Tumbled on Tuesday ↗
Via The Motley Fool
Topics Government
News headline image
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years ↗
Via The Motley Fool
News headline image
3 Monster Stocks in the Making ↗
Via The Motley Fool
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Down Nearly 20%: Should You Buy the Dip on Eli Lilly? ↗
Via The Motley Fool
Topics Earnings Government World Trade
News headline image
Why Viking Therapeutics Stock Surged Nearly 20% Higher in April ↗
Via The Motley Fool
News headline image
Why Viking Therapeutics Stock Was Victorious This Week ↗
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
34 35 Next >